Pacific Biosciences of California logo
Pacific Biosciences of California PACB
$ 1.95 0.78%

Quarterly report 2024-Q1
added 05-09-2024

report update icon

Pacific Biosciences of California Financial Statements 2011-2024 | PACB

Annual Financial Statements Pacific Biosciences of California

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

1.41 B 2.05 B 4.18 B 4.28 B 715 M 919 M 305 M 426 M 808 M 567 M 459 M 142 M 232 M

Shares

254 M 225 M 204 M 165 M 153 M 135 M 106 M 89.1 M 75.6 M 70.5 M 62.8 M 55.7 M 53.9 M

Historical Prices

5.57 9.11 20.5 25.9 5.14 7.4 2.64 3.8 13.1 7.84 5.23 1.7 2.8

Net Income

-307 M -314 M -181 M 29.4 M -84.1 M -103 M -92.2 M -74.4 M -31.7 M -66.2 M -79.3 M -94.5 M -109 M

Revenue

201 M 128 M 131 M 78.9 M 90.9 M 78.6 M 93.5 M 90.7 M 92.8 M 60.6 M 28.2 M 26 M 33.9 M

Cost of Revenue

148 M 79.3 M 71.7 M 46.3 M 56.3 M 53.5 M 58.8 M 46.6 M 39.3 M 37.2 M 21.8 M 25 M 20.8 M

Gross Profit

52.8 M 49 M 58.9 M 32.6 M 34.6 M 25.1 M 34.7 M 44.2 M 53.4 M 23.4 M 6.42 M 940 K 13 M

Operating Income

-334 M -307 M -210 M -104 M -101 M -101 M -89.8 M -71.2 M -29.1 M -62.9 M -77.5 M -94.3 M -110 M

Interest Expense

14.3 M 14.7 M 12.5 M 267 K 2.61 M 2.42 M 2.92 M 3.23 M 2.93 M 2.83 M 2.48 M 274 K 287 K

EBITDA

-323 M -298 M -203 M -98 M -90.6 M -93.8 M -81.3 M -67.4 M -48.5 M -58.6 M -71.9 M -87.7 M -104 M

Operating Expenses

387 M 356 M 269 M 137 M 135 M 126 M 124 M 115 M 106 M 86.3 M 84 M 95.3 M 123 M

General and Administrative Expenses

170 M 161 M 124 M 72.8 M 75.5 M 63.5 M 59.1 M 47.8 M 45.2 M 38 M 38.7 M 47.7 M 46.7 M

All numbers in USD currency

Quarterly Income Statement Pacific Biosciences of California

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

270 M 268 M 255 M 250 M 242 M 227 M 225 M 224 M 222 M 221 M 202 M 199 M 195 M 192 M 167 M 154 M 153 M 153 K 153 K 153 K 151 M 149 K 135 M 132 M 124 M 116 M 116 M 97.4 M 93 M 92.7 M 92.1 M 88.1 M 83.6 M 78.3 M 75.2 M 74.7 M 74.1 M 73.9 M 70.7 M 70.5 K 67.9 M 66.3 M 65.5 M 61.9 M 57.4 M 56.2 M 55.9 M 55.7 M 55.2 M 55 K 54.3 M 53.4 K 55 M

Net Income

-78.2 M - -66.9 M -69.8 M -88 M - -77 M -71.4 M -81.5 M - 16.5 M -41 M -87.4 M - -23.7 M -23.1 M 1.26 M -91 K -29.1 M -24.6 M -30.3 M -30.8 M -25 M -22.5 M -24.2 M -20.8 M -22 M -25.5 M -23.9 M -19 M -17.5 M -18.5 M -19.4 M -1.41 M 1.82 M -11.9 M -20.2 M -19 M -9.16 M -19.1 M -18.9 M -17.2 M -20.5 M -20.5 M -21.1 M -21.7 M -22.7 M -22.5 M -27.6 M - -29.3 M -22.5 M -34.8 M

Revenue

38.8 M - 55.7 M 47.6 M 38.9 M - 32.3 M 35.5 M 33.2 M - 34.9 M 30.6 M 29 M - 19.1 M 19.1 M 15.6 M 27.9 M 21.9 M 24.6 M 16.4 M 19.5 M 18.2 M 21.6 M 19.4 M 24.9 M 23.5 M 20.1 M 24.9 M 25.7 M 25.1 M 20.7 M 19.1 M 36.3 M 13.9 M 24.9 M 17.6 M 16.9 M 20.6 M 11.4 M 11.6 M 9.13 M 7.42 M 6.05 M 5.58 M 5.88 M 2.78 M 7.29 M 10 M - 10.5 M 10.6 M 270 K

Cost of Revenue

27.5 M - 37.8 M 32 M 29.1 M - 18.8 M 19.3 M 19 M - 19.5 M 16.9 M 16 M - 12 M 10.5 M 8.11 M - 15 M 15 M 11.3 M - 15 M 12.7 M 12.1 M - 15.3 M 12.1 M 16 M - 12.5 M 10.1 M 9.62 M - 7.37 M 10.4 M 11.7 M - 7.46 M 8.3 M 8.97 M - 6.18 M 4.99 M 4.65 M - 2.59 M 7.02 M 10.2 M - 7.19 M 2.73 M -

Gross Profit

11.3 M - 17.9 M 15.5 M 9.76 M - 13.5 M 16.2 M 14.2 M - 15.4 M 13.8 M 13 M - 7.06 M 6.61 M 7.49 M 12.9 M 6.91 M 9.61 M 5.12 M 5.75 M 3.19 M 8.86 M 7.3 M 9.49 M 8.23 M 8 M 8.94 M 11.4 M 12.6 M 10.6 M 9.5 M 26.5 M 6.55 M 14.5 M 5.93 M 4.44 M 13.2 M 3.13 M 2.68 M 3.19 M 1.24 M 1.06 M 930 K 627 K 190 K 275 K -152 K - 3.33 M 7.9 M 270 K

Operating Income

-81.4 M - -82.5 M -73.2 M -91.3 M - -74.6 M -68 M -77.5 M - -74.5 M -37.6 M -33.7 M - -24.2 M -23.5 M -32.7 M -17.9 M -28.1 M -24.4 M -30.1 M -30.6 M -24.7 M -21.7 M -23.9 M -20.5 M -21.6 M -24.4 M -23.3 M -17.9 M -16.7 M -18.1 M -18.6 M -1.06 M 2.61 M -11.4 M -19.3 M -17.9 M -8.41 M -18.3 M -18.2 M -17 M -19.9 M -20 M -20.6 M -21.7 M -22.6 M -22.6 M -27.5 M - - - -35 M

Interest Expense

3.58 M - 3.59 M 3.55 M 3.63 M - 3.66 M 3.68 M 3.7 M - 3.67 M 3.59 M 1.79 M 98 M 267 K 267 K 267 K - 664 K 644 K 625 K - 616 K 598 K 581 K - 633 K 826 K 838 K - 821 K 795 K 779 K - 741 K 715 K 697 K - 716 K 701 K 686 K - 686 K 673 K 426 K - 68 K 69 K -70 K - 156 K 188 K 158 K

EBITDA

-78.1 M - - - -88.5 M - -67.7 M -63.4 M -75.3 M - -69.5 M -34.4 M -32.1 M - -19.3 M -20.3 M -31.1 M -17.9 M -22.6 M -20.8 M -28.3 M -30.6 M -19.2 M -18.1 M -22.1 M -20.5 M -14.9 M -19.5 M -20.4 M -17.9 M -13.9 M -16.2 M -17.7 M -1.06 M 5.31 M -9.51 M -18.4 M -17.9 M -5.1 M -16 M -17 M -17 M -15.7 M -17.1 M -19.1 M -21.7 M -17.5 M -19.2 M -25.9 M - 4.3 M 2.86 M -33.5 M

Operating Expenses

92.6 M - 100 M 88.7 M 101 M - 88.2 M 84.2 M 91.7 M - 89.8 M 51.3 M 46.7 M - 31.2 M 30.1 M 40.2 M 30.8 M 35 M 34 M 35.3 M 36.4 M 27.9 M 30.6 M 31.2 M 30 M 29.8 M 32.4 M 32.2 M 29.2 M 29.4 M 28.7 M 28.1 M 27.5 M 3.94 M 25.9 M 25.3 M 22.3 M 21.6 M 21.4 M 20.9 M 20.2 M 21.2 M 21.1 M 21.5 M 22.3 M 22.8 M 22.8 M 27.4 M - 32.8 M 30.6 M 35.2 M

General and Administrative Expenses

43.8 M - 43.4 M 40.6 M 39.8 M - 36.8 M 39.3 M 39.8 M - 31.6 M 29.1 M 26.1 M - 14.8 M 15.1 M 24.9 M - 20.1 M 19.1 M 19.8 M - 13.5 M 14.9 M 14.9 M - 14 M 15.5 M 15.3 M - 11.9 M 11.2 M 11.7 M - 10.8 M 10.8 M 10.8 M - 9.88 M 8.99 M 9.15 M - 10.8 M 9.37 M 9.55 M - 10.1 M 11.6 M 15.3 M - 12.8 M 11 M 11.1 M

All numbers in USD currency